"We"re ahead of the pack" in the cannabinoid drug space, says CEO of synthetic drugmaker Corbus

Swiss drugmaker Novartis gets go-ahead from U.S. regulators to conduct tests of malaria drug against COVID-19. Francis Maguire reports......»»

The biopharma space bled along with the rest of the market and COVID-19 levered biotechs weren't spared either. read more.....»»

Ahead of a planned regulatory application early next year, a Triangle drugmaker has brought in more than $22 million. Morrisville-based Liquidia Technologies (Nasdaq: LQDA) has announced a stock purchase agreement with institutional investors.....»»

Generic drug maker Mylan NV (NASDAQ: MYL) reported Tuesday ahead of t.....»»

The biotech space saw muted activity in the week ended Aug. 30. Among the notable news of the week: Amgen, Inc. (NASDAQ: AMGN)'s $13.4-billion deal to buy the psoriasis drug Otezla from Celgene Corporation (NAS.....»»

Insys Therapeutics Inc (NASDAQ: INSY), which specializes in painkillers and synthetic cannabinoid drugs, reported Thursday after the close with a sharp decline in revenue and .....»»

Insys Therapeutics Inc (NASDAQ: INSY), which specializes in painkillers and synthetic cannabinoid drugs, reported Thursday after the close with a sharp decline in reve Latest Ratings for .....»»

A Chinese cancer drug developer is pushing ahead with an initial public offering in Hong Kong, despite a global markets rout and the recent poor performance of other biotechnology startups that have listed in the city......»»

Here's a roundup of top developments in the biotech space over the last 24 hours. No biotech stocks hit 52-week peaks Thursday. Down In The Dumps (Biotech stocks hitting 52-week lows on Jan. 24) read more.....»»

Here's a roundup of top developments in the biotech space ove.....»»

Datadog (NASDAQ:DDOG) shares are trading lower ahead of today's Q1 earnings report, which is scheduled for after the close today. Weak earnings from other names in the software space has weighed on sector sentiment for the session. read more.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) read more.....»»

The Morrisville-based drugmaker has raised an equity round has new leadership continues to seek to strengthen the company's position......»»

The potential for growth in the space market has been drawing attention from investors. And the space sector could get more attention over the next couple weeks with the Ark Funds space ETF set to launch as early as this coming Monday. read more.....»»

Biotech stocks reversed course and ended lower in the week ended March 26, drawing inspiration from the broad.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 2) read more.....»»

Pfizer and Moderna have improved manufacturing capabilities and plan to deliver doses to the US ahead of schedule. Dado Ruvic/Reuters Dado Ruvic/Reut.....»»

Shares of AstraZeneca were down 0.1% in trading on Monday after the drugmaker said it voluntarily withdrew an indication grant.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 19) read more.....»»

The plan for the 28-story, 600,000-square-foot tower includes 150 residential units, 11,000 square feet of new market space, a 210-room boutique hotel, 90,000 square feet of office space, and a 352-space parking garage......»»